Serum oxidative stress parameters of women with hypothyroidism

Acta Biomedica de l'Ateneo Parmense

Volumn 80, Issue 2, 2009, Pages 135-139

  Coria, Mariela Janet ^a   Pastrán, Adriana Inés ^b   Gimenez, Maria Sofia ^a  

^a UNIVERSIDAD NACIONAL DE SAN LUIS   (Argentina)

^b Complejo Sanitario San Luis ^*  (Argentina)

Author keywords

Hypothyroidism; Nitric oxide; Oxidative stress; Paraoxonase; Women

Indexed keywords

ARYLDIALKYLPHOSPHATASE; NITRIC OXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROTROPIN; THYROXINE; ARYLESTERASE; CARBOXYLESTERASE; PON1 PROTEIN, HUMAN; THYROID HORMONE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; HOSPITALIZATION; METABOLISM; MIDDLE AGED; SPECTROPHOTOMETRY;

ADULT; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; FEMALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; NITRIC OXIDE; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; SPECTROPHOTOMETRY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; THYROID HORMONES; YOUNG ADULT;

EID: 73349127833     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 2008, 18: 141-4.
2. Dursun B, Dursun E, Capraz I, Ozben T, Apaydin A, Su-leymanlar G. Are uremia, diabetes, and atherosclerosis linked with impaired antioxidant mechanisms? J Investig Med 2008; 56: 545-52.
3. Isman CA, Yegen BC, Alican I. Methimazole induced hy-pothyroidism in rats ameliorates oxidative injury in experimental colitis. J Endocrinol 2003; 177: 471-6.
4. Sarandöl E, Tas S, Dirican M, Serdar Z. Oxidative stress and serum paraoxonase activity in experimental hypothy-roidism: effect of vitamin E supplementation. Cell Biochem Funct 2005; 23: 1-8.
5. Krysiak R, Okopien B, Herman ZS. Subclinical thyroid disorders. Pol Merkur Lekarski 2006; 21: 573-8.
6. Octaviano FG, Handy DE, Loscalzo J. Redox regulation in the extracellular environment. Circ J 2008; 72: 1-16.
7. Aktan F. iNOS- mediated nitric oxide production and its regulation. Life Sci 2004; 75: 639-53.
8. Chen K, Pittman RN, Popel AS. Nitric Oxide in the vas-culature: Where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal 2008; 10: 1185-98.
9. Gur M, Yildiz A, Demirbag R, et al. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers. Coron Artery Dis 2007; 18: 89-95.
10. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8
11. Gatica LV, Vega VA, Zirulnik F, et al. Alterations in the lipid metabolism of rat aorta: effects of vitamin A deficiency. J Vasc Res 2006; 43: 602-10.
12. Taddei S, Caraccio N, Virdis A, Dardano A, et al. Impaired endothelium-dependent vasodilatation in subclinical hy-pothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003; 88: 3731-7.
13. Fernández V, Tapia G, Varela P, et al. Thyroid hormone-induced oxidative stress in rodents and humans: a comparative view and relation to redox regulation of gene expression. Comp Biochem Physiol C Toxicol Pharmacol 2006; 142: 231-9.
14. Kebapcilar L, Akinci B, Bayraktar F, et al. Plasma thiobar-bituric acid-reactive substance levels in subclinical hypothy-roidism. Med Princ Pract 2007; 16: 432-6.
15. Nanda N, Bobby Z, Hamide A, et al. Association between oxidative stress and coronary lipid risk factors in hypothy-roid women is independent of body mass index. Metabolism 2007; 56: 1350-5.
16. Erdamar H, Demirci H, Yaman H, et al.The effect of hy-pothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status. Clin Chem Lab Med 2008; 46: 1004-10.
17. Baskol G, Atmaca H, Tanriverdi F, et al. Oxidative stress and enzymatic antioxidant status in patients with hypothy-roidism before and after treatment. Exp Clin Endocrinol Diabetes 2007; 115: 522-6.
18. Ozcan O, Cakir E, Yaman H, et al. The effects of thyroxine replacement on the levels of serum asymmetric dimethylarginine (ADMA) and other biochemical cardiovascular risk markers in patients with subclinical hypothyroidism. Clin Endocrinol 2005; 63: 203-6.
19. Azizi F, Raiszadeh F, Solati M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest 2003; 26: 703-9.
20. Hampl R, Ostatnikova D, Celec P, et al. Short-term effect of soy consumption on thyroid hormone levels and correlation with phytoestrogen level in healthy subjects. Endocr Regul 2008; 453-61.
21. Köhrle J. Environment and endocrinology: the case of thy-roidology. Ann Endocrinol (Paris) 2008; 69: 116-22.
22. Lippi G, Montagnana M, Targher G, et al. Prevalence of folic acid and Vitamin B12 deficiencies in patients with thyroid disorders. Am J Med Sci 2008; 336: 50-2.